The metabolic syndrome and urolithiasis: a systematic review and meta-analysis

References

• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care. 2005;28:1769–1778
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428
   PubMed Web of Science ®Google Scholar
• Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–915
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–1235
   PubMed Web of Science ®Google Scholar
• Einollahi B, Naghii MR, Sepandi M. Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis. Endocr Regul. 2013;47:27–32
   PubMedGoogle Scholar
• Pak CY, Sakhaee K, Moe O, et al. Biochemical profile of stone forming patients with diabetes mellitus. Urology. 2003;61:523–527
   PubMed Web of Science ®Google Scholar
• Lieske JC, Peña de la Vega LS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: An update. Kidney Int. 2006;69:760–764
   PubMed Web of Science ®Google Scholar
• Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002;62:971–979
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Higashiura K, Nakagawa M, et al. Effects of hyperinsulinemia under the euglycemic condition on calcium and phosphate metabolism in non-obese normotensive subjects. Tohoku J Exp Med. 1995;177:271–278
   PubMedGoogle Scholar
• Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006;17:1422–1428
   PubMed Web of Science ®Google Scholar
• Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007;2:883–888
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486–2497
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553
   Google Scholar
• Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059–1062
   Google Scholar
• Grundy SM, Brewer Jr HB, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438
   PubMed Web of Science ®Google Scholar
• West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741–747
   PubMed Web of Science ®Google Scholar
• Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58:383–388
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ. Association of nephrolithiasis with metabolic syndrome and its components. Metabolism. 2013;62:808–813
   PubMed Web of Science ®Google Scholar
• Filgueiras Pinto Rde S, Almeida JR, Kang HC, Rosa ML, Lugon JR. Metabolic syndrome and associated urolithiasis in adults enrolled in a community-based health program. Fam Pract. 2013;30:276–281
   PubMedGoogle Scholar
• Rendina D, Mossetti G, De Filippo G, et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: Role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2009;24:900–906
   PubMedGoogle Scholar
• Borghi L, Meschi T, Guerra A, et al. Essential arterial hypertension and stone disease. Kidney Int. 1999;55:2397–2406
   PubMed Web of Science ®Google Scholar
• Mente A, Honey RJ, McLaughlin JM, Bull SB, Logan AG. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol. 2006;17:2567–2575
   PubMedGoogle Scholar
• Losito A, Nunzi EG, Covarelli C, Nunzi E, Ferrara G. Increased acid excretion in kidney stone formers with essential hypertension. Nephrol Dial Transplant. 2009;24:137–141
   PubMed Web of Science ®Google Scholar
• Strazzullo P, Barba G, Vuotto P, et al. Past history of nephrolithiasis and incidence of hypertension in men: A reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant. 2001;16:2232–2235
   PubMed Web of Science ®Google Scholar
• Madore F, Stampfer MJ, Rimm EB, Curhan GC. Nephrolithiasis and risk of hypertension. Am J Hypertens. 1998;11:46–53
   PubMed Web of Science ®Google Scholar
• Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol. 2008;179:570–574
   PubMed Web of Science ®Google Scholar
• Abate N, Chandalia M, Cabo-Chan Jr AV, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386–392
   PubMed Web of Science ®Google Scholar
• Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol. 2008;28:174–180
   PubMedGoogle Scholar
• Cupisti A, Meola M, D’Alessandro C, et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother. 2007;61:86–90
   PubMed Web of Science ®Google Scholar
• Taylor EN, Curhan GC. Determinants of 24-h urinary oxalate excretion. Clin J Am Soc Nephrol. 2008;3:1453–1460
   PubMed Web of Science ®Google Scholar
• Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010;183:2244–2248
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med. 2004;164:885–891
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497–504
   PubMed Web of Science ®Google Scholar
• McCarron DA, Morris CD, Cole C. Dietary calcium in human hypertension. Science. 1982; 217:267–269
   PubMed Web of Science ®Google Scholar
• McCarron DA, Morris CD, Stanton JL. Hypertension and calcium. Science. 1984;226:386–393
   PubMedGoogle Scholar
• Zemel MB. Calcium modulation of hypertension and obesity: Mechanisms and implications. J Am Coll Nutr. 2011;20:428S–435S; discussion 440S–442S
   Google Scholar
• Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT. Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal. 2007;21:426–431
   PubMed Web of Science ®Google Scholar
• Holoch PA, Tracy CR. Antioxidants and self-reported history of kidney stones: The national health and nutrition examination survey. J Endourol. 2011;25:1903–1908
   PubMed Web of Science ®Google Scholar
• Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant. 2011;26: 864–868
   PubMed Web of Science ®Google Scholar